White Papers

1. Beyond Automation: Transforming Clinical Trial Delivery Through Structured Information 10/23/2026

   Study build delays stem less from slow tasks than from protocol intent being reinterpreted at every handoff. Treating the protocol as structured, reusable information changes where AI and expertise belong.

2. Participant-Centric RTSM Designs: Supply Management For Advanced Therapies And DTP 10/23/2026

   Advanced therapies and home trials require participant-centric supply systems that manage identity, short usability windows and PII from order through destruction.

3. In Search Of A Cure For Low Enrollment In Oncology Clinical Trials 10/19/2026

   Delayed enrollment can cost oncology trials up to $250K per patient. Explore the barriers keeping patients out and practical ways to reach more of them faster.

4. The PMCF Decision Guide 10/14/2026

   Proposed EU reforms may remove standalone PMCF reporting, yet the duty to proactively collect clinical data remains. Method selection, notified body defense, and data-capture cost determine what comes next.

5. Everything Clinical Trial Leaders Need To Know About AI Agents 10/13/2026

   A practical guide to what agentic AI actually means for clinical trials, from ontologies and human-in-the-loop governance to continuous validation and the build-versus-buy decision.

6. What It Takes To Achieve Patient-Centric Clinical Trials 10/8/2026

   Patient centricity is shifting from separate initiatives to a connected operating model. Survey data from sponsors, CROs, and sites show where fragmentation persists and what is required.

7. Redesigning Regulatory Medical Writing For The AI Era 10/6/2026

   Faster drafts aren't faster submissions. See how to apply AI across medical writing with the governance and human review regulators expect.

8. Accelerating Drug Development: Insights From 2020–2024 Rapid Approvals 10/5/2026

   Some drugs reach approval in 3–5 years instead of 8–10. Learn which scientific, regulatory, and operational conditions can help your program cut avoidable delay.

9. Phase-Appropriate Signal Detection In Clinical Trials 10/5/2026

   Are your trial safety methods right for your phase? Learn a framework that keeps medical judgment central, avoids overreading sparse early data and catches rarer risks as studies grow.

10. Effectively Tailoring Treatments Based On Genetic & Molecular Profiling 9/30/2026

    Precision medicine is transforming hematology-oncology care by matching treatments to the distinct genetic and molecular profiles of each patient.